Form 4: Snap-on CFO Exercises Options, Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Snap-on's Senior VP of Finance and CFO, Aldo J. Pagliari, exercised stock options and subsequently sold a portion of the acquired shares under a pre-arranged 10b5-1 plan.
Summary
- Aldo J. Pagliari, Senior VP Finance & CFO of Snap-on Inc., executed transactions on February 19, 2026, pursuant to a Rule 10b5-1 Plan adopted on November 3, 2025.
- Pagliari exercised a stock option to acquire 10,000 shares of common stock at an exercise price of $168.7 per share.
- A total of 7,043 shares of common stock were sold to cover the exercise price and estimated tax liability.
- The sales were executed in multiple trades at weighted average prices ranging from $381.2361 to $384.1429 per share.
- Following these transactions, Pagliari beneficially owns 117,183.0556 shares of Snap-on Inc. common stock.
- Pagliari retains various unexercised stock options, restricted stock units, and performance units with future vesting and expiration dates, including 26,000 stock options at $161.18, 1,533 restricted stock units vesting in 2027, and 3,065 performance units tied to 2024-2026 company goals.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The transactions are routine insider activity under a pre-arranged 10b5-1 plan, not indicative of new discretionary sentiment.
Positives
- The exercise of stock options at a significantly lower price ($168.7) compared to the sale price (average around $382) indicates a substantial personal gain for the executive.
- The transactions were conducted under a pre-arranged Rule 10b5-1 Plan, demonstrating a structured approach to managing equity compensation and mitigating concerns about opportunistic insider trading.
Negatives
- The sale of 7,043 shares by a senior executive, even if pre-planned, reduces their direct equity stake in the company.
Future Outlook
The filing details future vesting schedules for various stock options, restricted stock units, and performance units, indicating ongoing equity compensation for the executive tied to continued employment and company performance goals through 2028.
Industry Context
StockSavvy.ai notes that insider transactions, particularly sales, are often scrutinized by investors for signals about management's confidence. However, transactions executed under a Rule 10b5-1 plan, as in this case, are pre-scheduled and typically do not reflect new discretionary selling decisions, thus mitigating concerns about immediate negative sentiment. Such plans are common practice for executives to manage their equity holdings and diversify their portfolios in compliance with insider trading regulations.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Authorization | Aldo J. Pagliari granted a Power of Attorney to several individuals, including Ryan S. Lovitz, to execute and file SEC Forms 3, 4, 5, and 144 on his behalf. This ensures timely and compliant reporting of insider transactions. | 2019-02-27 | Enhances efficiency and compliance for insider reporting by allowing designated attorneys-in-fact to handle filings. |
Stakeholder Impact
- Shareholders: The sale of shares by a senior executive, even under a 10b5-1 plan, slightly reduces the executive's direct alignment with shareholder interests, though the overall beneficial ownership remains substantial.
- Employees: The continued vesting of equity awards for the CFO signals ongoing executive compensation practices, which can be a factor in employee morale and retention for key personnel.
Next Steps
- Achievement of company goals over the 2024-2026, 2025-2027, and 2026-2028 periods for performance units to vest and stock to be awarded.
- Vesting of Restricted Stock Units on February 15, 2027, February 13, 2028, and February 12, 2029, assuming continued employment.
- Potential future exercise of remaining stock options with various vesting and expiration dates through 2036.
Key Dates
| Date | Description |
|---|---|
| 2019-02-27 | Date Power of Attorney was executed by Aldo J. Pagliari, authorizing others to file SEC forms on his behalf. |
| 2025-02-15 | Initial vesting date for 7,106 stock options at an exercise price of $269, expiring on 02/15/2034. |
| 2025-11-03 | Date the Rule 10b5-1 Plan was adopted by Aldo J. Pagliari. |
| 2026-02-13 | Initial vesting date for 5,342 stock options at an exercise price of $339.73, expiring on 02/13/2035. |
| 2026-02-19 | Transaction date for the exercise of stock options and subsequent sale of common stock by Aldo J. Pagliari. |
| 2026-02-19 | Date of signature for the Form 4 filing by Ryan S. Lovitz under Power of Attorney. |
| 2027-02-09 | Expiration date for the 10,000 stock options exercised on 02/19/2026. |
| 2027-02-12 | Initial vesting date for 5,187 stock options at an exercise price of $378.55, expiring on 02/12/2036. |
| 2027-02-15 | Vesting date for 1,533 Restricted Stock Units, assuming continued employment. |
| 2028-02-13 | Vesting date for 1,249 Restricted Stock Units, assuming continued employment. |
| 2028-02-15 | Expiration date for 26,052 stock options at an exercise price of $161.18. |
| 2029-02-12 | Vesting date for 1,249 Restricted Stock Units, assuming continued employment. |
| 2029-02-14 | Expiration date for 23,500 stock options at an exercise price of $155.92. |
| 2030-02-13 | Expiration date for 23,500 stock options at an exercise price of $155.34. |
| 2031-02-11 | Expiration date for 14,986 stock options at an exercise price of $189.89. |
| 2032-02-10 | Expiration date for 11,252 stock options at an exercise price of $211.67. |
| 2033-02-09 | Expiration date for 7,850 stock options at an exercise price of $249.26. |
| 2034-02-15 | Expiration date for 7,106 stock options at an exercise price of $269. |
| 2035-02-13 | Expiration date for 5,342 stock options at an exercise price of $339.73. |
| 2036-02-12 | Expiration date for 5,187 stock options at an exercise price of $378.55. |
Recommendation
holdThis Form 4 filing details a routine, pre-scheduled insider transaction by a senior executive under a Rule 10b5-1 plan. It does not provide new material information about the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. The transaction is a personal liquidity event for the executive and is generally considered neutral for the stock's outlook.
Keywords
Snap-on Inc, SNA, Insider Trading, Form 4, Stock Options, Equity Compensation, Rule 10b5-1 Plan, Executive Compensation, Aldo J. Pagliari
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.